Why patient centricity is no longer optional in ALS clinical trials

This webinar covered the vital need for patient involvement in ALS clinical trials in order to improve recruitment, retention and data quality, as well as readiness to adhere to impending regulatory changes. Featuring Paul Wicks, Ph.D., a neuropsychologist, independent consultant and Sano Genetics investor and Cathy Collet, a world-leading ALS advocate.


Our panel of experts

Cathy Collet-1

Cathy Collet

ALS advocate